We continually prove it’s possible to invent and advance affordable and effective medicines that prevent and treat diseases of poverty, like HIV, malaria, diarrheal disease, and infections—and to get them safely to people who need them.
Research and development (R&D) into new medical products is the engine driving progress toward health for all. Regulatory approvals are essential to ensuring the safety and efficacy of these products—but regulatory processes differ from country to country across Africa, resulting in delays in introduction and scale-up.
Diarrhea is more than just unpleasant. It’s deadly.
It doesn’t have any overt symptoms, but around the world, environmental enteric dysfunction (EED) causes lifelong harm to the most vulnerable children.
A lot of ugly things in nature are relatively harmless (Exhibit A: the star-nosed mole)—but Cryptosporidium isn’t one of them.
Women want and need access to a variety of contraceptives to plan, space, and prevent pregnancies. PATH is expanding access and options with DMPA-SC (brand name Sayana® Press), an all-in-one contraceptive that puts women in charge of their reproductive health.
The world has changed in remarkable—even unprecedented—ways since PATH got its start. Now we're accelerating our efforts to create greater health, equity, and opportunity everywhere.